The anti-fibrotic effect of thymoquinone on thioacetamide-induced mouse hepatic fibrosis
Ting Bai,Yong Yang,Li-hua Lian,Yan-ling Wu,Shuang Jiang,Hui-xing Zheng,Xin Li,Jin-bin Li,You-li Yao,Ji-xing Nan
DOI: https://doi.org/10.1038/aps.2013.109
IF: 7.169
2013-01-01
Acta Pharmacologica Sinica
Abstract:10.1038/aps.2013.109 S2.1 The anti-fibrotic effect of thymoquinone on thioacetamide-induced mouse hepatic fibrosis Ting BAI, Yong YANG, Li-hua LIAN, Yan-ling WU, Shuang JIANG, Hui-xing ZHENG, Xin LI, Jin-bin LI, You-li YAO, Ji-xing NAN*. Key Laboratory for Natural Resource of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, Yanji 133002, China *To whom correspondence should be addressed. E-mail: jxnanybu@gmail.com Aim: Thymoquinone (TQ) is the main active ingredient from the seeds of Nigella sativa Linn, which has been traditionally used in the Middle East and Southeast Asian countries to treat ailments including asthma, bronchitis, rheumatism, cancer and related inflammatory diseases. In the present study, we investigate the antifibrotic effect and the potential mechanisms of action of TQ against hepatic fibrosis in vivo. Methods: Liver fibrosis was induced by intraperitoneal injections of thioacetamide (TAA, 200 mg/kg) three weekly for 5 weeks in male kunming mice. The administration of TQ (20, 40 mg/kg) was started following TAA injections and was continued for 5 weeks to evaluate the protective effects by hematoxylin and eosin (H&E) staining and Masson staining. The protein and mRNA extracted from liver tissue were analyzed by Western blotting analysis and Real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR). Results: Our data demonstrated that treated with TQ obviously improved tissue damage compared with TAA-only group, in that less inflammatory cell infiltration was observed in H&E and Masson staining results. TQ demonstrated great efficacy in curing hepatic fibrosis via attenuating the TAA-mediated α-smooth muscle actin (α-SMA) and Collagen-I. TQ significantly inhibited the expression of toll-like receptor 4 (TLR4), tissue inhibitor of metalloproteinase-1 (TIMP-1) and α-SMA by Western blotting analysis and RT-PCR. TQ also significantly inhibited phosphatidylinositol 3-kinase (PI3K) phosphorylation and the phosphorylation adenosine monophosphateactivated protein kinase (AMPK) and liver kinase B (LKB)-1. Furthermore, TQ significantly decreased the expression of interleukin (IL)-1b and IL-18 in TAAinduced mouse hepatic fibrosis. Conclusion: The potential anti-fibrosis mechanism of TQ might be associated with the depression of α-SMA and Collagen-I relating with hepatic fibrosis, down-regulating the accompanying inflammatory response in hepatic fibrosis. TQ suppressed PI3K signaling and activated LKB-1 signaling in TAA-induced mouse hepatic fibrosis, suggesting that TQ may be a potential candidate for the therapy of hepatic fibrosis.